A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 3934
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : LVH
Long Form : left ventricular hypertrophy
No. Year Title Co-occurring Abbreviation
2020 Albuminuria and other target organ damage in Chinese patients with hypertension and diabetes: A data analysis based on the ATTEND study. CHD, CVD, DM, HTN
2020 ALU transposition induces familial hypertrophic cardiomyopathy. HCM, MLPA
2020 Antihypertensive therapy and sudden cardiac death, should we expect the unexpected? HTN, SCD
2020 Aspects of diastolic dysfunction in patients with new and recurrent depression. AS, DD, LVMI, MADRS, NOD, PWV, RD
2020 Association of Urine Albumin/Creatinine Ratio below 30 mg/g and Left Ventricular Hypertrophy in Patients with Type 2 Diabetes. AUC, OR, T2DM, UACR
2020 Associations of awake and asleep blood pressure and blood pressure dipping with abnormalities of cardiac structure: the Coronary Artery Risk Development in Young Adults study. ABPM, BP
2020 Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence. AL, AS, CA, HF, HRT, HRV
2020 Blood pressure and glucose control and the prevalence of albuminuria and left ventricular hypertrophy in patients with hypertension and diabetes. BP
2020 Clinical findings of gadolinium-enhanced cardiac magnetic resonance in Fabry patients. CMR, LGE
10  2020 Correction of QRS voltage for body mass index does not improve the prediction of fatal and nonfatal cardiovascular events. The Moli-sani study. BMI, CV, ECG, SL
11  2020 Current diagnostic ECG criteria for left ventricular hypertrophy: is it time to change paradigm in the analysis of data? ---
12  2020 Diagnostic utility of the electrocardiographic left ventricular hypertrophy criteria in specific populations. BMI, ECG, ECHO, IHD, NPV, PPV, Se, Sp
13  2020 Diagnostic yield of hypertrophic cardiomyopathy in first-degree relatives of decedents with idiopathic left ventricular hypertrophy. HCM
14  2020 Different Patterns of Left Ventricular Hypertrophy in Metabolically Healthy and Insulin-Resistant Obese Subjects. MHO
15  2020 Differentiation between Fabry disease and hypertrophic cardiomyopathy with cardiac T1 mapping. CMR, FD, HCM, MOLLI
16  2020 Distinct pressure half-time values by transthoracic echocardiography for grading of paravalvular regurgitation after transcatheter aortic valve replacement. AR, CMR, PHT, TAVR, TTE
17  2020 Early detection of left atrial dysfunction assessed by CMR feature tracking in hypertensive patients. CMR-FT, EF, HTN, LA, SRa, SRe
18  2020 Early Left Ventricular Systolic Dysfunction Detected by Two-Dimensional Speckle-Tracking Echocardiography in Young Patients with Congenital Generalized Lipodystrophy. CGL, ECHO, EF, GLS, LAVI, LVDS
19  2020 Effect of gasotransmitters treatment on expression of hypertension, vascular and cardiac remodeling and hypertensive nephropathy genes in left ventricular hypertrophy. NO
20  2020 FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. FGFR4, FGFR4, sK
21  2020 Good long-term renal graft survival and low incidence of cardiac pathology in adults after short dialysis period and renal transplantation in early childhood - a cohort study. CAC, PTH
22  2020 HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction. HDAC, HFpEF, LV
23  2020 High likelihood for atrial fibrillation in Cushing's syndrome. AF, AHT, CS, DM, HR, MI, PTE
24  2020 Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese. HHcy, LVMH2.7, LVMI, MetS, OR
25  2020 Identification of a Multiplex Biomarker Panel for Hypertrophic Cardiomyopathy Using Quantitative Proteomics and Machine Learning. HCM, ML, SCD
26  2020 Identification of High-Risk Left Ventricular Hypertrophy on Calcium Scoring Cardiac Computed Tomography Scans: Validation in the DHS. CAC-CT, DHS
27  2020 Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction. HFpEF, LV
28  2020 Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy. 99mTc-PYP, hs-cTnT, IVS, LVEF, RWT
29  2020 Left Ventricular Hypertrophy and Late Gadolinium Enhancement at Cardiac MRI Are Associated with Adverse Cardiac Events in Fabry Disease. CI, HR, LGE
30  2020 Left Ventricular Hypertrophy and Mortality Risk in Male Veteran Patients at High Cardiovascular Risk. CI, HR, LVM/BSA
31  2020 Left ventricular hypertrophy in isolated and dual masked hypertension. ABP, BP, LVM, MH
32  2020 Limitations of Electrocardiography for Detecting Left Ventricular Hypertrophy or Concentric Remodeling in Athletes. AUC, CI, ECG, LVM
33  2020 Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients. BMI, ECG
34  2020 Predictive value of traditional risk factors for cardiovascular disease in older people: A systematic review. AHM, BMI, CVD, HDL, SBP, TRFs
35  2020 Pretransplant left ventricular hypertrophy in association with postoperative myocardial injury in liver transplantation. LT, PMI
36  2020 Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy. CA
37  2020 Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies. CI, RR
38  2020 Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multi-Cohort Study. ARIC, DHS, HF, MESA, PAF
39  2020 Ratio of Fabry disease in patients with idiopathic left ventricular hypertrophy: A single-center study in Turkey. alpha-Gal A, FD, LV
40  2020 The electrical determinants of increased wall thickness and mass in left ventricular hypertrophy. A-ECG, AUC, CI, ECG, GTI, LVM, LVMI
41  2020 The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis. AF, ESRD
42  2020 The Relationship Between Homocysteine, Blood Pressure Variability, and Left Ventricular Hypertrophy in Patients with Essential Hypertension: An Observational Study. BPV, Hcy
43  2020 Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry. HF, LVEF, OCEAN-TAVI, post-AR, pre-AR, TAVI
44  2019 2017 Pediatric Hypertension Guidelines Improve Prediction of Adult Cardiovascular Outcomes. ---
45  2019 A cross-sectional study of the ambulatory central artery stiffness index in patients with hypertension. AASI, AcASI, BABP, CABP, LVMI, MBP, PP, PWV
46  2019 A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome e and left ventricular hypertrophy: A multicenter, randomized, double-blind, placebo-controlled trial. BP, LVM, MS
47  2019 A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial. CAD, CV, IR
48  2019 Ambulatory blood pressures and central blood pressures are associated with cardiovascular morbidity in adolescent and young adult patients receiving chronic hemodialysis. ABPM, BP, CBP, CV, HD, LVMI, PWV
49  2019 Antihypertensive therapy prevents new-onset atrial fibrillation in patients with isolated systolic hypertension: the LIFE study. AF, ECG, ISH, LIFE, SBP
50  2019 Aortic-flow propagation velocity is associated with proteinuria and left ventricular hypertrophy in newly diagnosed hypertensive patients. ABI, APV, CIMT, TOD
51  2019 Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation". AHCM, APA, CCT, CMR, LGE, LV, MPI
52  2019 Assessment of Cardiac Involvement in Fabry Disease (FD) with Native T1 Mapping. FD, MOLLI
53  2019 Assessment of myocardial oxygenation, strain, and diastology in MYBPC3-related hypertrophic cardiomyopathy: a cardiovascular magnetic resonance and echocardiography study. BOLD, HCM, LV, NC
54  2019 Association between cardiovascular autonomic neuropathy and left ventricular hypertrophy in young patients with congenital generalized lipodystrophy. CAN, CGL, CIMT, HF, HRV, IVS, LF, LVMI, TAS, VLF
55  2019 Association Between High-Sensitivity Cardiac Troponin T and Echocardiographic Parameters in Chronic Kidney Disease: Results From the KNOW-CKD Cohort Study. CKD, hs-TnT
56  2019 Association of Blood Pressure Level With Left Ventricular Mass in Adolescents. BP, LVMI, SBP
57  2019 Association of Cardiac Injury and Malignant Left Ventricular Hypertrophy With Risk of Heart Failure in African Americans: The Jackson Heart Study. HF, hs-cTnI
58  2019 Association of left bundle branch block with new onset abnormal wall motion in treated hypertensive patients with left ventricle hypertrophy: the LIFE Echo Sub-study. ECG, LBBB, LV
59  2019 Association of OPG-RANKL ratio with left ventricular hypertrophy and geometric remodeling in male overweight/obese youths. LVMI, RWT
60  2019 Awareness and appropriateness of the management of preclinical heart failure in outpatient clinics in Italy: Insights from the VASTISSIMO study - EValuation of the AppropriateneSs of The preclInical phase (Stage A and Stage B) of Heart FaIlure Management in Outpatient Clinics in Italy. AMI, HF
61  2019 Better Myocardial Function in Aortic Stenosis with Low Left Ventricular Mass: A Mechanism of Protection against Heart Failure Regardless of Stenosis Severity? AS, cESS, EF, HF, LV
62  2019 Blood Pressure Profile, Catecholamine Phenotype, and Target Organ Damage in Pheochromocytoma/Paraganglioma. BP, NA, PPGL, PWV, TOD
63  2019 Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation toOutcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial. hs
64  2019 Cardio- Renal Outcomes With Long- Term Agalsidase Alfa Enzyme Replacement Therapy: A 10- Year Fabry Outcome Survey (FOS) Analysis. eGFR, ERT, FOS, LVMI
65  2019 Cardio-omentopexy Reduces Cardiac Fibrosis and Heart Failure After Experimental Pressure Overload. ---
66  2019 Cardiovascular disease risk among children with focal segmental glomerulosclerosis: a report from the chronic kidney disease in children study. APBM, BP, CIMT, CKD, CKiD, CVD, FSGS, LVMI
67  2019 Cardiovascular remodelling in patients with pre-dialysis chronic kidney disease and renal transplant recipients. CAA, CKD, CVD, eGFR, RTR
68  2019 Cardiovascular risk in primary aldosteronism: A systematic review and meta-analysis. CCV, DBP, EH, MD, PA, RR, SBP
69  2019 Change in left ventricular geometry over 10 years in the elderly and risk of incident cardiovascular disease. HR, LV, LVEDD, LVMI
70  2019 Changes in left ventricular filling parameters before and after dialysis in patients with end stage renal disease. DD, ESRD, HD
71  2019 Changes in serum and intracardiac fibroblast growth factor 23 during the progression of left ventricular hypertrophy in hypertensive model rats. FGF23, SHR
72  2019 Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212. AMPK, CKD, ERK2, FOXO3, HFpEF, miR-212, mTOR, NFAT
73  2019 Chronic Pressure Overload Results in Deficiency of Mitochondrial Membrane Transporter ABCB7 Which Contributes to Iron Overload, Mitochondrial Dysfunction, Metabolic Shift and Worsens Cardiac Function. LV, mtOXPHOS, ROS
74  2019 Circulating CTRP1 Levels Are Increased and Associated with the STOD in Essential Hypertension in Chinese Patients. APN, CTRP1, EH, ELISA, IL-6, MAU, STOD, TNF-alpha
75  2019 Clinical and Immunological Profile of Anti-factor H Antibody Associated Atypical Hemolytic Uremic Syndrome: A Nationwide Database. aHUS, AKI, CIC, FH, GEE, PEX, SRBC
76  2019 CMR derived left ventricular septal convexity in carriers of the hypertrophic cardiomyopathy-causing MYBPC3-Q1061X mutation. CMR, HCM
77  2019 Comparing the performance of artificial intelligence and conventional diagnosis criteria for detecting left ventricular hypertrophy using electrocardiography. AI, ECG, ENN
78  2019 Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study. CP, ECG, ECG-LVH, ECHO, ECHO-LVH, LVM/BSA, SL, TOD
79  2019 Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review. CV, ECG, HMOD
80  2019 Cornell product in an electrocardiogram is related to reduced LV regional wall motion. LVMI
81  2019 Correlation of Echocardiogram and Exercise Test Data in Children with Aortic Stenosis. AS, SBP
82  2019 Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? GLS, GRS, HCM, Ph
83  2019 Data driven feature selection and machine learning to detect misplaced V1 and V2 chest electrodes when recording the 12‑lead electrocardiogram. ECG, ICS
84  2019 Deletion Polymorphism of Angiotensin Converting Enzyme Gene is Associated with Left Ventricular Hypertrophy in Uighur Hypertension-Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Patients. ACE, NLVH, OSAHS
85  2019 Detection of Left Ventricular Hypertrophy Using Bayesian Additive Regression Trees: The MESA. BART, MESA
86  2019 Diagnosis and Prevention of Hypertensive Heart Failure. BP, HF
87  2019 Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging. BMI, CMR, ECG
88  2019 Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy. BSA, cLVH, ECG, eLVH
89  2019 Diastolic dysfunction grading, echocardiographic and electrocardiogram findings in 50 patients with apical hypertrophic cardiomyopathy. Apical HCM, ASE, ECG, LV
90  2019 Diastolic dysfunction in asymptomatic hemodialysis patients in the light of the current echocardiographic guidelines. BNP
91  2019 Distinctive ECG patterns in healthy black adults. ARVC, ER, STE, STEMI, TWI
92  2019 DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease. CKD, DMP1, FGF23, WT
93  2019 Do treatment-induced changes in arterial stiffness affect left ventricular structure? A meta-analysis. LVM, LVMI, PWV
94  2019 Dysregulation of proangiogeneic factors in pressure-overload left-ventricular hypertrophy results in inadequate capillary growth. SDF1, TAC, VEGF
95  2019 Early reversal cardiac with esmolol in hypertensive rats: The role of subcellular organelle phenotype. SHRs, WKY
96  2019 Early reversal cardiac with esmolol in hypertensive rats: The role of subcellular organelle phenotype. SHRs, WKY
97  2019 ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death. ECG, SCD
98  2019 Echocardiographic Correlation between Right Ventricular Function and Left Atrial Volume. LAV, LVDD, RV, TAPSE
99  2019 Echocardiographic strain in hypertrophic cardiomyopathy and hypertensive left ventricular hypertrophy. CS, HCM, LS, RS
100  2019 Echocardiography in Low-Risk Hypertensive Patients. ---